phase readout
saveNCT03803774: Birinapant and Intensity Modulated Re-Irradiation Therapy in Treating Patients With Locally Recurrent Head and Neck Squamous Cell Carcinoma
ACTIVE_NOT_RECRUITINGupdated 5d ago
community read0 votes
Sponsor: National Cancer Institute (NCI). Phase: PHASE1. Conditions: Locally Recurrent Head and Neck Squamous Cell Carcinoma, Nasopharyngeal Squamous Cell Carcinoma, Sinonasal Squamous Cell Carcinoma
view source ↗
comments(0)
5-min edit window · permanent after that